Soleno Therapeutics, Inc.
www.soleno.lifeSoleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program in early 2018.
Read more
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program in early 2018.
Read more
Country
State
California
City (Headquarters)
Redwood City
Industry
Employees
1-10
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Cmc
Email ****** @****.comPhone (***) ****-****Senior Vice President of Drug Development
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(21)
Reach decision makers at Soleno Therapeutics, Inc.
Free credits every month!
Soleno Therapeutics, Inc. FAQ
Redwood City, United States
Pharmaceutical Manufacturing
We'll help you understand if Lusha can solve your business needs.
